AAAAAA

   
Results: 1-10 |
Results: 10
Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules
Authors: Green, JRB Lobo, AJ Giaffer, M Travis, S Watkins, HC
Citation: Jrb. Green et al., Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules, ALIM PHARM, 15(9), 2001, pp. 1331-1341
Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status
Authors: Parsons, HK Carter, MJ Sanders, DS Winstanley, T Lobo, AJ
Citation: Hk. Parsons et al., Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status, ALIM PHARM, 15(9), 2001, pp. 1473-1478
Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care
Authors: Sanders, DS Carter, MJ Hurlstone, DP Pearce, A Ward, AM McAlindon, ME Lobo, AJ
Citation: Ds. Sanders et al., Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care, LANCET, 358(9292), 2001, pp. 1504-1508
Research outcomes in British gastroenterology: an audit of the subsequent full publication of abstracts presented at the British Society of Gastroenterology
Authors: Sanders, DS Carter, MJ Lobo, AJ Hoggard, N
Citation: Ds. Sanders et al., Research outcomes in British gastroenterology: an audit of the subsequent full publication of abstracts presented at the British Society of Gastroenterology, GUT, 49(1), 2001, pp. 154-155
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians
Authors: Carter, MJ di Giovine, FS Jones, S Mee, J Camp, NJ Lobo, AJ Duff, GW
Citation: Mj. Carter et al., Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians, GUT, 48(4), 2001, pp. 461-467
Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease
Authors: Carter, MJ Lobo, AJ
Citation: Mj. Carter et Aj. Lobo, Lack of effect of intravenous azathioprine on time to respond for steroid treated Crohn's disease, GUT, 48(3), 2001, pp. 295-296
The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis
Authors: Carter, MJ Di Giovine, FS Cox, A Goodfellow, P Jones, S Shorthouse, AJ Duff, GW Lobo, AJ
Citation: Mj. Carter et al., The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis, GASTROENTY, 121(4), 2001, pp. 805-811
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis
Authors: Green, JR Lobo, AJ Holdsworth, CD
Citation: Jr. Green et al., Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis, GUT, 44(4), 1999, pp. 455-455
Matrix metalloproteinase levels are elevated in inflammatory bowel disease
Authors: Baugh, MD Perry, MJ Hollander, AP Davies, DR Cross, SS Lobo, AJ Taylor, CJ Evans, GS
Citation: Md. Baugh et al., Matrix metalloproteinase levels are elevated in inflammatory bowel disease, GASTROENTY, 117(4), 1999, pp. 814-822
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months
Authors: Green, JRB Gibson, JA Kerr, GD Swarbrick, ET Lobo, AJ Holdsworth, CD Crowe, JP Schofield, KJ Taylor, MD
Citation: Jrb. Green et al., Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months, ALIM PHARM, 12(12), 1998, pp. 1207-1216
Risultati: 1-10 |